RAC Past Papers PowerPoint PPT Presentation

presentation player overlay
About This Presentation
Transcript and Presenter's Notes

Title: RAC Past Papers


1
Pass Regulatory Affairs Certification (RAC)
Global Scope exam in just 24 HOURS! 100 REAL
EXAM QUESTIONS ANSWERS Regulatory Affairs
Certification (RAC) Global Scope Buy Complete
Questions Answers File from http//www.exams4sure.
net/raps/rac-gs-exam-questions-dumps.html 100
Exam Passing Guarantee Money Back Assurance
2
  • Sample Questions
  • Question 1
  • Which of the following statements regarding the
    off-label use of drugs is CORRECT?
  • Although the regulatory authority reviews and
    approves drugs for specific indications, the
    approval does not limit the use of those drugs in
    clinical practice.
  • The regulatory authority does not restrict
    physician prescribing for off-label
  • indications or regulate the manufacturer's
    promotion for such use.
  • Sponsors are allowed to distribute publications
    about unapproved uses of approved drugs and
    devices as long as the marketing application is
    under review by the regulatory authority.
  • The peer-reviewed literature can ensure
    high-quality off-label promotion of medications,
    thereby increasing access to much needed drugs
    and devices.
  • Answer A
  • Question 2
  • A drug product presents degradation during the
    manufacturing process. In addition to the
    amount, what information should be provided FIRST
    in order to use API overage?
  • Specification
  • Formulation
  • Property
  • Justification
  • Answer D
  • Question 3

3
  • requirement and received approval. Which action
    should the regulatory affairs professional take
    FIRST?
  • Discuss with the regulatory apriority and attempt
    to reach an acceptable solution.
  • Inform the internal departments to redesign the
    product to comply with this requirement.
  • Inform the regulatory authority that such a
    requirement is not applicable to the product.
  • Notify senior management that the product cannot
    be registered.
  • Answer A
  • Question 4
  • Which of the following statements regarding
    export regulations for an approved product is
    CORRECT?
  • The product must not be in accord with the
    specifications of the foreign purchaser.
  • The product must not be in conflict with the laws
    of the country to which it is intended for
    export.
  • The product must not be labeled on the outside of
    the shipping package that it is intended for
    export.
  • The product must not be sold or offered for sale
    in domestic commerce.
  • Answer B
  • Question 5
  • The intermediate manufacturing process was
    changed during development of a pharmaceutical.
    The change may impact the API specification.
    Which functional area is responsible for the
    final approval of the change?
  • Production
  • Analytical

4
  • Question 6
  • Under which of the following circumstances would
    a regulatory authority require a more detailed
    premarket submission, a more rigorous audit,
    and/or the provision of more performance
    evaluation data than would normally apply to an
    IVD device of that risk class?
  • The device is an updated version of a compliant
    device from the same manufacturer and contains
    no substantive change.
  • Internationally recognized standards are
    available to cover the main aspects of the
    device and have been used by the manufacturer.
  • The manufacturer's experience level with the type
    of IVD medical device is limited.
  • The device incorporates well-established
    technology that is already present in the
    market.
  • Answer C
  • Question 7
  • According to WHO, what are the temperature and
    humidity conditions for a Zone IVb long term
    stability study?
  • 25 C and 60 RH
  • 30 C and 35 RH
  • 30c C and 65 RH
  • 30 C and 75 RH
  • Answer D
  • Question 8

5
  • any regulatory action." Which action would be the
    most appropriate FIRST step for the company to
    take?
  • Contact the regulatory authority to argue that
    its conclusions are wrong.
  • Contact the regulatory authority to discuss its
    findings.
  • Repeat the Hepatotoxicity tests and send the
    results to the regulatory authority.
  • Wait for the regulatory authority's final
    publication on its findings.
  • Answer B
  • Buy Complete Questions Answers File from
  • http//www.exams4sure.net/raps/rac-gs-exam-questio
    ns-dumps.html
  • 100 Exam Passing Guarantee Money Back
    Assurance
  • PDF Version Test Engine Software Version
  • 90 Days Free Updates Service
  • Valid For All Countries

6
http//www.exams4sure.net/raps/rac-gs-exam-questio
ns-dumps.html
Write a Comment
User Comments (0)